nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A7—Tacrolimus—atopic dermatitis	0.0947	0.138	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Tacrolimus—atopic dermatitis	0.0947	0.138	CbGbCtD
Oxycodone—CYP3A5—Tacrolimus—atopic dermatitis	0.071	0.103	CbGbCtD
Oxycodone—CYP3A4—Pimecrolimus—atopic dermatitis	0.0466	0.0677	CbGbCtD
Oxycodone—CYP3A7—Hydrocortisone—atopic dermatitis	0.0385	0.0561	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Hydrocortisone—atopic dermatitis	0.0385	0.0561	CbGbCtD
Oxycodone—CYP2D6—Loratadine—atopic dermatitis	0.0319	0.0464	CbGbCtD
Oxycodone—CYP2D6—Diphenhydramine—atopic dermatitis	0.0319	0.0464	CbGbCtD
Oxycodone—CYP3A5—Hydrocortisone—atopic dermatitis	0.0289	0.042	CbGbCtD
Oxycodone—CYP3A4—Tacrolimus—atopic dermatitis	0.0277	0.0403	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Dexamethasone—atopic dermatitis	0.024	0.0349	CbGbCtD
Oxycodone—CYP3A7—Dexamethasone—atopic dermatitis	0.024	0.0349	CbGbCtD
Oxycodone—CYP3A4—Loratadine—atopic dermatitis	0.0203	0.0295	CbGbCtD
Oxycodone—CYP3A4—Methylprednisolone—atopic dermatitis	0.0185	0.027	CbGbCtD
Oxycodone—CYP3A5—Dexamethasone—atopic dermatitis	0.018	0.0261	CbGbCtD
Oxycodone—CYP3A4—Triamcinolone—atopic dermatitis	0.014	0.0204	CbGbCtD
Oxycodone—CYP3A4—Betamethasone—atopic dermatitis	0.0121	0.0175	CbGbCtD
Oxycodone—CYP3A4—Prednisolone—atopic dermatitis	0.0119	0.0173	CbGbCtD
Oxycodone—CYP3A4—Hydrocortisone—atopic dermatitis	0.0113	0.0164	CbGbCtD
Oxycodone—CYP3A4—Prednisone—atopic dermatitis	0.0112	0.0163	CbGbCtD
Oxycodone—CYP2D6—Dexamethasone—atopic dermatitis	0.011	0.016	CbGbCtD
Oxycodone—CYP3A4—Dexamethasone—atopic dermatitis	0.00701	0.0102	CbGbCtD
Oxycodone—OPRM1—Peptide ligand-binding receptors—TAC1—atopic dermatitis	0.000164	0.00443	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—NPS—atopic dermatitis	0.000164	0.00443	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CXCR3—atopic dermatitis	0.000161	0.00434	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.00016	0.00433	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCL27—atopic dermatitis	0.000159	0.0043	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CCL11—atopic dermatitis	0.000155	0.0042	CbGpPWpGaD
Oxycodone—OPRM1—TCR Signaling Pathway—NFKBIA—atopic dermatitis	0.000155	0.00419	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CCR3—atopic dermatitis	0.000155	0.00419	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.000154	0.00415	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.000151	0.00409	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000151	0.00408	CbGpPWpGaD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000149	0.00402	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.000148	0.00401	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.000148	0.00401	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.000148	0.00399	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000146	0.00394	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000145	0.00393	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.000144	0.00389	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCL17—atopic dermatitis	0.000143	0.00386	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCL11—atopic dermatitis	0.000136	0.00368	CbGpPWpGaD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000136	0.00367	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CXCR3—atopic dermatitis	0.000135	0.00366	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000132	0.00357	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00013	0.00351	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00013	0.00351	CbGpPWpGaD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CXCL10—atopic dermatitis	0.00013	0.00351	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00013	0.0035	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000127	0.00345	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000127	0.00344	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CCR3—atopic dermatitis	0.000127	0.00342	CbGpPWpGaD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.000126	0.0034	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL22—atopic dermatitis	0.000124	0.00334	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.000123	0.00333	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000121	0.00328	CbGpPWpGaD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000119	0.00322	CbGpPWpGaD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000117	0.00318	CbGpPWpGaD
Oxycodone—Loss of consciousness—Triamcinolone—atopic dermatitis	0.000115	0.000418	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—CCL11—atopic dermatitis	0.000115	0.00311	CbGpPWpGaD
Oxycodone—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.000115	0.000418	CcSEcCtD
Oxycodone—OPRM1—TCR Signaling Pathway—CD4—atopic dermatitis	0.000115	0.00311	CbGpPWpGaD
Oxycodone—Rash—Tacrolimus—atopic dermatitis	0.000115	0.000417	CcSEcCtD
Oxycodone—Dermatitis—Tacrolimus—atopic dermatitis	0.000115	0.000417	CcSEcCtD
Oxycodone—OPRD1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.000115	0.0031	CbGpPWpGaD
Oxycodone—Shock—Prednisolone—atopic dermatitis	0.000115	0.000416	CcSEcCtD
Oxycodone—Cough—Triamcinolone—atopic dermatitis	0.000114	0.000415	CcSEcCtD
Oxycodone—Headache—Tacrolimus—atopic dermatitis	0.000114	0.000414	CcSEcCtD
Oxycodone—Oedema—Hydrocortisone—atopic dermatitis	0.000114	0.000413	CcSEcCtD
Oxycodone—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000114	0.000413	CcSEcCtD
Oxycodone—Convulsion—Triamcinolone—atopic dermatitis	0.000114	0.000413	CcSEcCtD
Oxycodone—Tachycardia—Prednisolone—atopic dermatitis	0.000114	0.000412	CcSEcCtD
Oxycodone—Convulsion—Methylprednisolone—atopic dermatitis	0.000113	0.000412	CcSEcCtD
Oxycodone—Infection—Hydrocortisone—atopic dermatitis	0.000113	0.00041	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—TAC1—atopic dermatitis	0.000113	0.00305	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—NPS—atopic dermatitis	0.000113	0.00305	CbGpPWpGaD
Oxycodone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.000113	0.000409	CcSEcCtD
Oxycodone—Shock—Hydrocortisone—atopic dermatitis	0.000112	0.000406	CcSEcCtD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CCL5—atopic dermatitis	0.000112	0.00302	CbGpPWpGaD
Oxycodone—Myalgia—Triamcinolone—atopic dermatitis	0.000112	0.000405	CcSEcCtD
Oxycodone—OPRK1—G alpha (i) signalling events—CCL5—atopic dermatitis	0.000112	0.00302	CbGpPWpGaD
Oxycodone—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.000111	0.000405	CcSEcCtD
Oxycodone—Arthralgia—Methylprednisolone—atopic dermatitis	0.000111	0.000404	CcSEcCtD
Oxycodone—Myalgia—Methylprednisolone—atopic dermatitis	0.000111	0.000404	CcSEcCtD
Oxycodone—Eye disorder—Prednisone—atopic dermatitis	0.000111	0.000404	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—CCR3—atopic dermatitis	0.000111	0.003	CbGpPWpGaD
Oxycodone—Anxiety—Methylprednisolone—atopic dermatitis	0.000111	0.000403	CcSEcCtD
Oxycodone—Tachycardia—Hydrocortisone—atopic dermatitis	0.000111	0.000403	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000111	0.00299	CbGpPWpGaD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.000111	0.000402	CcSEcCtD
Oxycodone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00011	0.00299	CbGpPWpGaD
Oxycodone—Flushing—Prednisone—atopic dermatitis	0.00011	0.000401	CcSEcCtD
Oxycodone—Skin disorder—Hydrocortisone—atopic dermatitis	0.00011	0.000401	CcSEcCtD
Oxycodone—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00011	0.000401	CcSEcCtD
Oxycodone—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00011	0.000401	CcSEcCtD
Oxycodone—Discomfort—Triamcinolone—atopic dermatitis	0.00011	0.000401	CcSEcCtD
Oxycodone—OPRD1—Signaling by GPCR—CCL27—atopic dermatitis	0.00011	0.00298	CbGpPWpGaD
Oxycodone—Discomfort—Methylprednisolone—atopic dermatitis	0.00011	0.0004	CcSEcCtD
Oxycodone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.00011	0.000399	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00011	0.00297	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00011	0.00297	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CXCL10—atopic dermatitis	0.00011	0.00296	CbGpPWpGaD
Oxycodone—Dry mouth—Triamcinolone—atopic dermatitis	0.000109	0.000396	CcSEcCtD
Oxycodone—Angioedema—Betamethasone—atopic dermatitis	0.000109	0.000395	CcSEcCtD
Oxycodone—Angioedema—Dexamethasone—atopic dermatitis	0.000109	0.000395	CcSEcCtD
Oxycodone—OPRK1—Signaling by GPCR—CCL22—atopic dermatitis	0.000108	0.00293	CbGpPWpGaD
Oxycodone—Anorexia—Hydrocortisone—atopic dermatitis	0.000108	0.000393	CcSEcCtD
Oxycodone—Nausea—Tacrolimus—atopic dermatitis	0.000108	0.000393	CcSEcCtD
Oxycodone—Angiopathy—Prednisone—atopic dermatitis	0.000108	0.000392	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.000108	0.00291	CbGpPWpGaD
Oxycodone—Confusional state—Methylprednisolone—atopic dermatitis	0.000108	0.000391	CcSEcCtD
Oxycodone—Immune system disorder—Prednisone—atopic dermatitis	0.000108	0.00039	CcSEcCtD
Oxycodone—Malaise—Betamethasone—atopic dermatitis	0.000107	0.00039	CcSEcCtD
Oxycodone—Malaise—Dexamethasone—atopic dermatitis	0.000107	0.00039	CcSEcCtD
Oxycodone—Oedema—Triamcinolone—atopic dermatitis	0.000107	0.000389	CcSEcCtD
Oxycodone—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000107	0.000389	CcSEcCtD
Oxycodone—Vertigo—Dexamethasone—atopic dermatitis	0.000107	0.000388	CcSEcCtD
Oxycodone—Vertigo—Betamethasone—atopic dermatitis	0.000107	0.000388	CcSEcCtD
Oxycodone—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000107	0.000388	CcSEcCtD
Oxycodone—Syncope—Betamethasone—atopic dermatitis	0.000107	0.000387	CcSEcCtD
Oxycodone—Syncope—Dexamethasone—atopic dermatitis	0.000107	0.000387	CcSEcCtD
Oxycodone—OPRK1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000106	0.00288	CbGpPWpGaD
Oxycodone—OPRD1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000106	0.00288	CbGpPWpGaD
Oxycodone—Infection—Triamcinolone—atopic dermatitis	0.000106	0.000386	CcSEcCtD
Oxycodone—Hypotension—Hydrocortisone—atopic dermatitis	0.000106	0.000386	CcSEcCtD
Oxycodone—OPRM1—TCR Signaling Pathway—IL1B—atopic dermatitis	0.000106	0.00287	CbGpPWpGaD
Oxycodone—Infection—Methylprednisolone—atopic dermatitis	0.000106	0.000385	CcSEcCtD
Oxycodone—Shock—Triamcinolone—atopic dermatitis	0.000105	0.000382	CcSEcCtD
Oxycodone—Insomnia—Prednisolone—atopic dermatitis	0.000105	0.000382	CcSEcCtD
Oxycodone—Shock—Methylprednisolone—atopic dermatitis	0.000105	0.000381	CcSEcCtD
Oxycodone—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.000105	0.00038	CcSEcCtD
Oxycodone—Loss of consciousness—Dexamethasone—atopic dermatitis	0.000105	0.00038	CcSEcCtD
Oxycodone—Loss of consciousness—Betamethasone—atopic dermatitis	0.000105	0.00038	CcSEcCtD
Oxycodone—Paraesthesia—Prednisolone—atopic dermatitis	0.000105	0.000379	CcSEcCtD
Oxycodone—Tachycardia—Triamcinolone—atopic dermatitis	0.000104	0.000379	CcSEcCtD
Oxycodone—Mental disorder—Prednisone—atopic dermatitis	0.000104	0.000379	CcSEcCtD
Oxycodone—Tachycardia—Methylprednisolone—atopic dermatitis	0.000104	0.000378	CcSEcCtD
Oxycodone—Skin disorder—Methylprednisolone—atopic dermatitis	0.000104	0.000377	CcSEcCtD
Oxycodone—Malnutrition—Prednisone—atopic dermatitis	0.000104	0.000376	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000104	0.000376	CcSEcCtD
Oxycodone—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.000103	0.000376	CcSEcCtD
Oxycodone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.000103	0.000375	CcSEcCtD
Oxycodone—Convulsion—Dexamethasone—atopic dermatitis	0.000103	0.000374	CcSEcCtD
Oxycodone—Convulsion—Betamethasone—atopic dermatitis	0.000103	0.000374	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000103	0.00279	CbGpPWpGaD
Oxycodone—Insomnia—Hydrocortisone—atopic dermatitis	0.000103	0.000373	CcSEcCtD
Oxycodone—Paraesthesia—Hydrocortisone—atopic dermatitis	0.000102	0.000371	CcSEcCtD
Oxycodone—Myalgia—Dexamethasone—atopic dermatitis	0.000101	0.000368	CcSEcCtD
Oxycodone—Myalgia—Betamethasone—atopic dermatitis	0.000101	0.000368	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000101	0.00273	CbGpPWpGaD
Oxycodone—Anxiety—Betamethasone—atopic dermatitis	0.000101	0.000367	CcSEcCtD
Oxycodone—Anxiety—Dexamethasone—atopic dermatitis	0.000101	0.000367	CcSEcCtD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CCR5—atopic dermatitis	0.000101	0.00272	CbGpPWpGaD
Oxycodone—OPRK1—G alpha (i) signalling events—CCR5—atopic dermatitis	0.0001	0.00272	CbGpPWpGaD
Oxycodone—Discomfort—Betamethasone—atopic dermatitis	0.0001	0.000363	CcSEcCtD
Oxycodone—Discomfort—Dexamethasone—atopic dermatitis	0.0001	0.000363	CcSEcCtD
Oxycodone—Dyspepsia—Hydrocortisone—atopic dermatitis	0.0001	0.000363	CcSEcCtD
Oxycodone—Hypotension—Methylprednisolone—atopic dermatitis	9.98e-05	0.000362	CcSEcCtD
Oxycodone—Pain—Prednisolone—atopic dermatitis	9.95e-05	0.000361	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—NPS—atopic dermatitis	9.9e-05	0.00268	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—TAC1—atopic dermatitis	9.9e-05	0.00268	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL17—atopic dermatitis	9.89e-05	0.00267	CbGpPWpGaD
Oxycodone—Decreased appetite—Hydrocortisone—atopic dermatitis	9.88e-05	0.000359	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	9.81e-05	0.000356	CcSEcCtD
Oxycodone—Fatigue—Hydrocortisone—atopic dermatitis	9.8e-05	0.000356	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	9.75e-05	0.000354	CcSEcCtD
Oxycodone—OPRM1—TCR Signaling Pathway—MAPK8—atopic dermatitis	9.73e-05	0.00263	CbGpPWpGaD
Oxycodone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	9.73e-05	0.000353	CcSEcCtD
Oxycodone—Pain—Hydrocortisone—atopic dermatitis	9.72e-05	0.000353	CcSEcCtD
Oxycodone—Anaphylactic shock—Dexamethasone—atopic dermatitis	9.71e-05	0.000353	CcSEcCtD
Oxycodone—Oedema—Dexamethasone—atopic dermatitis	9.71e-05	0.000353	CcSEcCtD
Oxycodone—Anaphylactic shock—Betamethasone—atopic dermatitis	9.71e-05	0.000353	CcSEcCtD
Oxycodone—Oedema—Betamethasone—atopic dermatitis	9.71e-05	0.000353	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—CXCR3—atopic dermatitis	9.71e-05	0.00262	CbGpPWpGaD
Oxycodone—Insomnia—Triamcinolone—atopic dermatitis	9.68e-05	0.000351	CcSEcCtD
Oxycodone—OPRK1—Signaling by GPCR—CCL27—atopic dermatitis	9.67e-05	0.00261	CbGpPWpGaD
Oxycodone—Insomnia—Methylprednisolone—atopic dermatitis	9.66e-05	0.000351	CcSEcCtD
Oxycodone—Infection—Betamethasone—atopic dermatitis	9.65e-05	0.00035	CcSEcCtD
Oxycodone—Infection—Dexamethasone—atopic dermatitis	9.65e-05	0.00035	CcSEcCtD
Oxycodone—Ill-defined disorder—Prednisone—atopic dermatitis	9.61e-05	0.000349	CcSEcCtD
Oxycodone—Paraesthesia—Triamcinolone—atopic dermatitis	9.61e-05	0.000349	CcSEcCtD
Oxycodone—Feeling abnormal—Prednisolone—atopic dermatitis	9.59e-05	0.000348	CcSEcCtD
Oxycodone—Paraesthesia—Methylprednisolone—atopic dermatitis	9.59e-05	0.000348	CcSEcCtD
Oxycodone—Anaemia—Prednisone—atopic dermatitis	9.58e-05	0.000348	CcSEcCtD
Oxycodone—Shock—Betamethasone—atopic dermatitis	9.55e-05	0.000347	CcSEcCtD
Oxycodone—Shock—Dexamethasone—atopic dermatitis	9.55e-05	0.000347	CcSEcCtD
Oxycodone—Dyspnoea—Triamcinolone—atopic dermatitis	9.54e-05	0.000346	CcSEcCtD
Oxycodone—Nervous system disorder—Betamethasone—atopic dermatitis	9.52e-05	0.000346	CcSEcCtD
Oxycodone—Nervous system disorder—Dexamethasone—atopic dermatitis	9.52e-05	0.000346	CcSEcCtD
Oxycodone—Agitation—Prednisone—atopic dermatitis	9.52e-05	0.000346	CcSEcCtD
Oxycodone—Tachycardia—Dexamethasone—atopic dermatitis	9.48e-05	0.000344	CcSEcCtD
Oxycodone—Tachycardia—Betamethasone—atopic dermatitis	9.48e-05	0.000344	CcSEcCtD
Oxycodone—Angioedema—Prednisone—atopic dermatitis	9.47e-05	0.000344	CcSEcCtD
Oxycodone—OPRM1—G alpha (i) signalling events—CCL5—atopic dermatitis	9.43e-05	0.00255	CbGpPWpGaD
Oxycodone—Dyspepsia—Triamcinolone—atopic dermatitis	9.42e-05	0.000342	CcSEcCtD
Oxycodone—Dyspepsia—Methylprednisolone—atopic dermatitis	9.4e-05	0.000341	CcSEcCtD
Oxycodone—Hyperhidrosis—Dexamethasone—atopic dermatitis	9.39e-05	0.000341	CcSEcCtD
Oxycodone—Hyperhidrosis—Betamethasone—atopic dermatitis	9.39e-05	0.000341	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—CCR3—atopic dermatitis	9.38e-05	0.00254	CbGpPWpGaD
Oxycodone—Feeling abnormal—Hydrocortisone—atopic dermatitis	9.37e-05	0.00034	CcSEcCtD
Oxycodone—Malaise—Prednisone—atopic dermatitis	9.34e-05	0.000339	CcSEcCtD
Oxycodone—OPRK1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	9.33e-05	0.00252	CbGpPWpGaD
Oxycodone—Vertigo—Prednisone—atopic dermatitis	9.31e-05	0.000338	CcSEcCtD
Oxycodone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	9.29e-05	0.000337	CcSEcCtD
Oxycodone—Syncope—Prednisone—atopic dermatitis	9.29e-05	0.000337	CcSEcCtD
Oxycodone—Anorexia—Betamethasone—atopic dermatitis	9.26e-05	0.000336	CcSEcCtD
Oxycodone—Anorexia—Dexamethasone—atopic dermatitis	9.26e-05	0.000336	CcSEcCtD
Oxycodone—Urticaria—Prednisolone—atopic dermatitis	9.25e-05	0.000336	CcSEcCtD
Oxycodone—Fatigue—Triamcinolone—atopic dermatitis	9.23e-05	0.000335	CcSEcCtD
Oxycodone—Fatigue—Methylprednisolone—atopic dermatitis	9.21e-05	0.000334	CcSEcCtD
Oxycodone—OPRM1—Signaling by GPCR—CCL22—atopic dermatitis	9.17e-05	0.00248	CbGpPWpGaD
Oxycodone—Pain—Triamcinolone—atopic dermatitis	9.15e-05	0.000332	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	9.11e-05	0.00246	CbGpPWpGaD
Oxycodone—Loss of consciousness—Prednisone—atopic dermatitis	9.11e-05	0.000331	CcSEcCtD
Oxycodone—Hypotension—Betamethasone—atopic dermatitis	9.07e-05	0.000329	CcSEcCtD
Oxycodone—Hypotension—Dexamethasone—atopic dermatitis	9.07e-05	0.000329	CcSEcCtD
Oxycodone—Urticaria—Hydrocortisone—atopic dermatitis	9.03e-05	0.000328	CcSEcCtD
Oxycodone—OPRM1—GPCR downstream signaling—CCL27—atopic dermatitis	9e-05	0.00243	CbGpPWpGaD
Oxycodone—Abdominal pain—Hydrocortisone—atopic dermatitis	8.99e-05	0.000326	CcSEcCtD
Oxycodone—Body temperature increased—Hydrocortisone—atopic dermatitis	8.99e-05	0.000326	CcSEcCtD
Oxycodone—Convulsion—Prednisone—atopic dermatitis	8.98e-05	0.000326	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—CXCL10—atopic dermatitis	8.95e-05	0.00242	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	8.87e-05	0.0024	CbGpPWpGaD
Oxycodone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	8.85e-05	0.000321	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	8.85e-05	0.000321	CcSEcCtD
Oxycodone—Arthralgia—Prednisone—atopic dermatitis	8.82e-05	0.00032	CcSEcCtD
Oxycodone—Myalgia—Prednisone—atopic dermatitis	8.82e-05	0.00032	CcSEcCtD
Oxycodone—Feeling abnormal—Triamcinolone—atopic dermatitis	8.82e-05	0.00032	CcSEcCtD
Oxycodone—Feeling abnormal—Methylprednisolone—atopic dermatitis	8.8e-05	0.00032	CcSEcCtD
Oxycodone—Anxiety—Prednisone—atopic dermatitis	8.79e-05	0.000319	CcSEcCtD
Oxycodone—Insomnia—Dexamethasone—atopic dermatitis	8.78e-05	0.000319	CcSEcCtD
Oxycodone—Insomnia—Betamethasone—atopic dermatitis	8.78e-05	0.000319	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	8.76e-05	0.000318	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	8.73e-05	0.000317	CcSEcCtD
Oxycodone—Paraesthesia—Dexamethasone—atopic dermatitis	8.72e-05	0.000317	CcSEcCtD
Oxycodone—Paraesthesia—Betamethasone—atopic dermatitis	8.72e-05	0.000317	CcSEcCtD
Oxycodone—Discomfort—Prednisone—atopic dermatitis	8.72e-05	0.000316	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	8.71e-05	0.00235	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL17—atopic dermatitis	8.67e-05	0.00234	CbGpPWpGaD
Oxycodone—Hypersensitivity—Prednisolone—atopic dermatitis	8.57e-05	0.000311	CcSEcCtD
Oxycodone—Dyspepsia—Dexamethasone—atopic dermatitis	8.55e-05	0.00031	CcSEcCtD
Oxycodone—Dyspepsia—Betamethasone—atopic dermatitis	8.55e-05	0.00031	CcSEcCtD
Oxycodone—Urticaria—Triamcinolone—atopic dermatitis	8.5e-05	0.000309	CcSEcCtD
Oxycodone—OPRM1—G alpha (i) signalling events—CCR5—atopic dermatitis	8.49e-05	0.0023	CbGpPWpGaD
Oxycodone—Urticaria—Methylprednisolone—atopic dermatitis	8.48e-05	0.000308	CcSEcCtD
Oxycodone—Body temperature increased—Triamcinolone—atopic dermatitis	8.46e-05	0.000307	CcSEcCtD
Oxycodone—Oedema—Prednisone—atopic dermatitis	8.46e-05	0.000307	CcSEcCtD
Oxycodone—Anaphylactic shock—Prednisone—atopic dermatitis	8.46e-05	0.000307	CcSEcCtD
Oxycodone—Abdominal pain—Methylprednisolone—atopic dermatitis	8.44e-05	0.000307	CcSEcCtD
Oxycodone—Decreased appetite—Betamethasone—atopic dermatitis	8.44e-05	0.000307	CcSEcCtD
Oxycodone—Decreased appetite—Dexamethasone—atopic dermatitis	8.44e-05	0.000307	CcSEcCtD
Oxycodone—Infection—Prednisone—atopic dermatitis	8.4e-05	0.000305	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	8.38e-05	0.000304	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	8.38e-05	0.000304	CcSEcCtD
Oxycodone—Hypersensitivity—Hydrocortisone—atopic dermatitis	8.37e-05	0.000304	CcSEcCtD
Oxycodone—Fatigue—Betamethasone—atopic dermatitis	8.37e-05	0.000304	CcSEcCtD
Oxycodone—Fatigue—Dexamethasone—atopic dermatitis	8.37e-05	0.000304	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—TAC1—atopic dermatitis	8.36e-05	0.00226	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—NPS—atopic dermatitis	8.36e-05	0.00226	CbGpPWpGaD
Oxycodone—Shock—Prednisone—atopic dermatitis	8.32e-05	0.000302	CcSEcCtD
Oxycodone—Pain—Betamethasone—atopic dermatitis	8.3e-05	0.000302	CcSEcCtD
Oxycodone—Pain—Dexamethasone—atopic dermatitis	8.3e-05	0.000302	CcSEcCtD
Oxycodone—Nervous system disorder—Prednisone—atopic dermatitis	8.29e-05	0.000301	CcSEcCtD
Oxycodone—Tachycardia—Prednisone—atopic dermatitis	8.25e-05	0.0003	CcSEcCtD
Oxycodone—Skin disorder—Prednisone—atopic dermatitis	8.21e-05	0.000298	CcSEcCtD
Oxycodone—OPRD1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	8.21e-05	0.00222	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCR3—atopic dermatitis	8.2e-05	0.00222	CbGpPWpGaD
Oxycodone—Hyperhidrosis—Prednisone—atopic dermatitis	8.18e-05	0.000297	CcSEcCtD
Oxycodone—OPRM1—Signaling by GPCR—CCL27—atopic dermatitis	8.17e-05	0.00221	CbGpPWpGaD
Oxycodone—Asthenia—Hydrocortisone—atopic dermatitis	8.16e-05	0.000296	CcSEcCtD
Oxycodone—Anorexia—Prednisone—atopic dermatitis	8.06e-05	0.000293	CcSEcCtD
Oxycodone—Pruritus—Hydrocortisone—atopic dermatitis	8.04e-05	0.000292	CcSEcCtD
Oxycodone—Feeling abnormal—Betamethasone—atopic dermatitis	8e-05	0.000291	CcSEcCtD
Oxycodone—Feeling abnormal—Dexamethasone—atopic dermatitis	8e-05	0.000291	CcSEcCtD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	7.99e-05	0.00216	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL11—atopic dermatitis	7.97e-05	0.00216	CbGpPWpGaD
Oxycodone—Gastrointestinal pain—Betamethasone—atopic dermatitis	7.94e-05	0.000288	CcSEcCtD
Oxycodone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	7.94e-05	0.000288	CcSEcCtD
Oxycodone—Hypersensitivity—Triamcinolone—atopic dermatitis	7.89e-05	0.000286	CcSEcCtD
Oxycodone—OPRM1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	7.88e-05	0.00213	CbGpPWpGaD
Oxycodone—Hypersensitivity—Methylprednisolone—atopic dermatitis	7.87e-05	0.000286	CcSEcCtD
Oxycodone—OPRD1—Signaling Pathways—FCER2—atopic dermatitis	7.86e-05	0.00213	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CXCL10—atopic dermatitis	7.85e-05	0.00212	CbGpPWpGaD
Oxycodone—Diarrhoea—Hydrocortisone—atopic dermatitis	7.78e-05	0.000282	CcSEcCtD
Oxycodone—Urticaria—Betamethasone—atopic dermatitis	7.71e-05	0.00028	CcSEcCtD
Oxycodone—Urticaria—Dexamethasone—atopic dermatitis	7.71e-05	0.00028	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	7.71e-05	0.00028	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—CCL5—atopic dermatitis	7.7e-05	0.00208	CbGpPWpGaD
Oxycodone—Dizziness—Prednisolone—atopic dermatitis	7.7e-05	0.000279	CcSEcCtD
Oxycodone—Asthenia—Triamcinolone—atopic dermatitis	7.68e-05	0.000279	CcSEcCtD
Oxycodone—Body temperature increased—Dexamethasone—atopic dermatitis	7.68e-05	0.000279	CcSEcCtD
Oxycodone—Body temperature increased—Betamethasone—atopic dermatitis	7.68e-05	0.000279	CcSEcCtD
Oxycodone—Abdominal pain—Dexamethasone—atopic dermatitis	7.68e-05	0.000279	CcSEcCtD
Oxycodone—Abdominal pain—Betamethasone—atopic dermatitis	7.68e-05	0.000279	CcSEcCtD
Oxycodone—Asthenia—Methylprednisolone—atopic dermatitis	7.66e-05	0.000278	CcSEcCtD
Oxycodone—Insomnia—Prednisone—atopic dermatitis	7.65e-05	0.000278	CcSEcCtD
Oxycodone—Paraesthesia—Prednisone—atopic dermatitis	7.59e-05	0.000276	CcSEcCtD
Oxycodone—Pruritus—Triamcinolone—atopic dermatitis	7.57e-05	0.000275	CcSEcCtD
Oxycodone—Pruritus—Methylprednisolone—atopic dermatitis	7.56e-05	0.000274	CcSEcCtD
Oxycodone—Dizziness—Hydrocortisone—atopic dermatitis	7.52e-05	0.000273	CcSEcCtD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	7.5e-05	0.00203	CbGpPWpGaD
Oxycodone—Dyspepsia—Prednisone—atopic dermatitis	7.44e-05	0.00027	CcSEcCtD
Oxycodone—Decreased appetite—Prednisone—atopic dermatitis	7.35e-05	0.000267	CcSEcCtD
Oxycodone—Rash—Prednisolone—atopic dermatitis	7.34e-05	0.000266	CcSEcCtD
Oxycodone—Dermatitis—Prednisolone—atopic dermatitis	7.33e-05	0.000266	CcSEcCtD
Oxycodone—OPRM1—Signaling by GPCR—CCL17—atopic dermatitis	7.33e-05	0.00198	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL22—atopic dermatitis	7.31e-05	0.00198	CbGpPWpGaD
Oxycodone—Diarrhoea—Methylprednisolone—atopic dermatitis	7.31e-05	0.000265	CcSEcCtD
Oxycodone—Fatigue—Prednisone—atopic dermatitis	7.29e-05	0.000265	CcSEcCtD
Oxycodone—Headache—Prednisolone—atopic dermatitis	7.29e-05	0.000265	CcSEcCtD
Oxycodone—Constipation—Prednisone—atopic dermatitis	7.23e-05	0.000263	CcSEcCtD
Oxycodone—Vomiting—Hydrocortisone—atopic dermatitis	7.23e-05	0.000262	CcSEcCtD
Oxycodone—OPRK1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	7.2e-05	0.00195	CbGpPWpGaD
Oxycodone—Rash—Hydrocortisone—atopic dermatitis	7.17e-05	0.00026	CcSEcCtD
Oxycodone—Dermatitis—Hydrocortisone—atopic dermatitis	7.16e-05	0.00026	CcSEcCtD
Oxycodone—OPRD1—GPCR downstream signaling—CCR3—atopic dermatitis	7.16e-05	0.00193	CbGpPWpGaD
Oxycodone—Headache—Hydrocortisone—atopic dermatitis	7.12e-05	0.000259	CcSEcCtD
Oxycodone—Dizziness—Triamcinolone—atopic dermatitis	7.08e-05	0.000257	CcSEcCtD
Oxycodone—Dizziness—Methylprednisolone—atopic dermatitis	7.06e-05	0.000256	CcSEcCtD
Oxycodone—OPRK1—Signaling by GPCR—CCL11—atopic dermatitis	6.99e-05	0.00189	CbGpPWpGaD
Oxycodone—Feeling abnormal—Prednisone—atopic dermatitis	6.97e-05	0.000253	CcSEcCtD
Oxycodone—Asthenia—Betamethasone—atopic dermatitis	6.97e-05	0.000253	CcSEcCtD
Oxycodone—Asthenia—Dexamethasone—atopic dermatitis	6.97e-05	0.000253	CcSEcCtD
Oxycodone—OPRD1—GPCR ligand binding—CCR5—atopic dermatitis	6.94e-05	0.00188	CbGpPWpGaD
Oxycodone—OPRD1—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.93e-05	0.00187	CbGpPWpGaD
Oxycodone—Gastrointestinal pain—Prednisone—atopic dermatitis	6.92e-05	0.000251	CcSEcCtD
Oxycodone—Nausea—Prednisolone—atopic dermatitis	6.91e-05	0.000251	CcSEcCtD
Oxycodone—OPRK1—Signaling Pathways—FCER2—atopic dermatitis	6.89e-05	0.00186	CbGpPWpGaD
Oxycodone—Pruritus—Betamethasone—atopic dermatitis	6.87e-05	0.000249	CcSEcCtD
Oxycodone—Pruritus—Dexamethasone—atopic dermatitis	6.87e-05	0.000249	CcSEcCtD
Oxycodone—Vomiting—Triamcinolone—atopic dermatitis	6.8e-05	0.000247	CcSEcCtD
Oxycodone—Vomiting—Methylprednisolone—atopic dermatitis	6.79e-05	0.000247	CcSEcCtD
Oxycodone—OPRK1—GPCR ligand binding—CCL5—atopic dermatitis	6.75e-05	0.00183	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	6.75e-05	0.00183	CbGpPWpGaD
Oxycodone—Nausea—Hydrocortisone—atopic dermatitis	6.75e-05	0.000245	CcSEcCtD
Oxycodone—Rash—Triamcinolone—atopic dermatitis	6.75e-05	0.000245	CcSEcCtD
Oxycodone—Dermatitis—Triamcinolone—atopic dermatitis	6.74e-05	0.000245	CcSEcCtD
Oxycodone—Rash—Methylprednisolone—atopic dermatitis	6.73e-05	0.000244	CcSEcCtD
Oxycodone—Dermatitis—Methylprednisolone—atopic dermatitis	6.73e-05	0.000244	CcSEcCtD
Oxycodone—Urticaria—Prednisone—atopic dermatitis	6.72e-05	0.000244	CcSEcCtD
Oxycodone—Headache—Triamcinolone—atopic dermatitis	6.7e-05	0.000243	CcSEcCtD
Oxycodone—Headache—Methylprednisolone—atopic dermatitis	6.69e-05	0.000243	CcSEcCtD
Oxycodone—Body temperature increased—Prednisone—atopic dermatitis	6.69e-05	0.000243	CcSEcCtD
Oxycodone—Abdominal pain—Prednisone—atopic dermatitis	6.69e-05	0.000243	CcSEcCtD
Oxycodone—Diarrhoea—Betamethasone—atopic dermatitis	6.64e-05	0.000241	CcSEcCtD
Oxycodone—Diarrhoea—Dexamethasone—atopic dermatitis	6.64e-05	0.000241	CcSEcCtD
Oxycodone—OPRM1—GPCR ligand binding—CXCL10—atopic dermatitis	6.63e-05	0.00179	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL27—atopic dermatitis	6.51e-05	0.00176	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCR3—atopic dermatitis	6.5e-05	0.00176	CbGpPWpGaD
Oxycodone—Dizziness—Betamethasone—atopic dermatitis	6.42e-05	0.000233	CcSEcCtD
Oxycodone—Dizziness—Dexamethasone—atopic dermatitis	6.42e-05	0.000233	CcSEcCtD
Oxycodone—OPRK1—Signaling Pathways—CCL22—atopic dermatitis	6.41e-05	0.00173	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—NPS—atopic dermatitis	6.38e-05	0.00172	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—TAC1—atopic dermatitis	6.38e-05	0.00172	CbGpPWpGaD
Oxycodone—Nausea—Triamcinolone—atopic dermatitis	6.36e-05	0.000231	CcSEcCtD
Oxycodone—Nausea—Methylprednisolone—atopic dermatitis	6.34e-05	0.00023	CcSEcCtD
Oxycodone—OPRK1—GPCR downstream signaling—CCR3—atopic dermatitis	6.28e-05	0.0017	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCR3—atopic dermatitis	6.26e-05	0.00169	CbGpPWpGaD
Oxycodone—Hypersensitivity—Prednisone—atopic dermatitis	6.23e-05	0.000226	CcSEcCtD
Oxycodone—OPRM1—TCR Signaling Pathway—IL6—atopic dermatitis	6.22e-05	0.00168	CbGpPWpGaD
Oxycodone—Vomiting—Betamethasone—atopic dermatitis	6.17e-05	0.000224	CcSEcCtD
Oxycodone—Vomiting—Dexamethasone—atopic dermatitis	6.17e-05	0.000224	CcSEcCtD
Oxycodone—Rash—Betamethasone—atopic dermatitis	6.12e-05	0.000222	CcSEcCtD
Oxycodone—Rash—Dexamethasone—atopic dermatitis	6.12e-05	0.000222	CcSEcCtD
Oxycodone—Dermatitis—Betamethasone—atopic dermatitis	6.12e-05	0.000222	CcSEcCtD
Oxycodone—Dermatitis—Dexamethasone—atopic dermatitis	6.12e-05	0.000222	CcSEcCtD
Oxycodone—OPRM1—Peptide ligand-binding receptors—CXCL8—atopic dermatitis	6.09e-05	0.00165	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CCR5—atopic dermatitis	6.08e-05	0.00164	CbGpPWpGaD
Oxycodone—Headache—Betamethasone—atopic dermatitis	6.08e-05	0.000221	CcSEcCtD
Oxycodone—Headache—Dexamethasone—atopic dermatitis	6.08e-05	0.000221	CcSEcCtD
Oxycodone—OPRK1—G alpha (i) signalling events—CXCL8—atopic dermatitis	6.08e-05	0.00164	CbGpPWpGaD
Oxycodone—Asthenia—Prednisone—atopic dermatitis	6.07e-05	0.00022	CcSEcCtD
Oxycodone—Pruritus—Prednisone—atopic dermatitis	5.98e-05	0.000217	CcSEcCtD
Oxycodone—OPRD1—GPCR downstream signaling—IL5—atopic dermatitis	5.93e-05	0.0016	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL11—atopic dermatitis	5.91e-05	0.0016	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL17—atopic dermatitis	5.84e-05	0.00158	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FCER2—atopic dermatitis	5.83e-05	0.00157	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—NPS—atopic dermatitis	5.79e-05	0.00157	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—TAC1—atopic dermatitis	5.79e-05	0.00157	CbGpPWpGaD
Oxycodone—Diarrhoea—Prednisone—atopic dermatitis	5.79e-05	0.00021	CcSEcCtD
Oxycodone—Nausea—Betamethasone—atopic dermatitis	5.77e-05	0.000209	CcSEcCtD
Oxycodone—Nausea—Dexamethasone—atopic dermatitis	5.77e-05	0.000209	CcSEcCtD
Oxycodone—OPRK1—Signaling Pathways—CCL27—atopic dermatitis	5.71e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCL5—atopic dermatitis	5.71e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR3—atopic dermatitis	5.7e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCR3—atopic dermatitis	5.68e-05	0.00154	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—TAC1—atopic dermatitis	5.59e-05	0.00151	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—NPS—atopic dermatitis	5.59e-05	0.00151	CbGpPWpGaD
Oxycodone—Dizziness—Prednisone—atopic dermatitis	5.59e-05	0.000203	CcSEcCtD
Oxycodone—OPRD1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	5.51e-05	0.00149	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCR3—atopic dermatitis	5.48e-05	0.00148	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL22—atopic dermatitis	5.42e-05	0.00146	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL5—atopic dermatitis	5.38e-05	0.00146	CbGpPWpGaD
Oxycodone—Vomiting—Prednisone—atopic dermatitis	5.38e-05	0.000195	CcSEcCtD
Oxycodone—Rash—Prednisone—atopic dermatitis	5.33e-05	0.000194	CcSEcCtD
Oxycodone—Dermatitis—Prednisone—atopic dermatitis	5.33e-05	0.000193	CcSEcCtD
Oxycodone—OPRM1—GPCR downstream signaling—CCR3—atopic dermatitis	5.3e-05	0.00143	CbGpPWpGaD
Oxycodone—Headache—Prednisone—atopic dermatitis	5.3e-05	0.000192	CcSEcCtD
Oxycodone—OPRD1—Signaling Pathways—KIF3A—atopic dermatitis	5.21e-05	0.00141	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL5—atopic dermatitis	5.2e-05	0.00141	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CCR5—atopic dermatitis	5.14e-05	0.00139	CbGpPWpGaD
Oxycodone—OPRM1—G alpha (i) signalling events—CXCL8—atopic dermatitis	5.13e-05	0.00139	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL17—atopic dermatitis	5.12e-05	0.00138	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—TAC1—atopic dermatitis	5.08e-05	0.00137	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—NPS—atopic dermatitis	5.08e-05	0.00137	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL10—atopic dermatitis	5.06e-05	0.00137	CbGpPWpGaD
Oxycodone—Nausea—Prednisone—atopic dermatitis	5.02e-05	0.000182	CcSEcCtD
Oxycodone—OPRK1—Signaling by GPCR—CXCR3—atopic dermatitis	4.98e-05	0.00135	CbGpPWpGaD
Oxycodone—OPRK1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.83e-05	0.00131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL27—atopic dermatitis	4.83e-05	0.0013	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR3—atopic dermatitis	4.82e-05	0.0013	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—GLB1—atopic dermatitis	4.74e-05	0.00128	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—NPS—atopic dermatitis	4.73e-05	0.00128	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—TAC1—atopic dermatitis	4.73e-05	0.00128	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL5—atopic dermatitis	4.72e-05	0.00128	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL11—atopic dermatitis	4.71e-05	0.00127	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CMA1—atopic dermatitis	4.71e-05	0.00127	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCR3—atopic dermatitis	4.64e-05	0.00125	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL10—atopic dermatitis	4.59e-05	0.00124	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KIF3A—atopic dermatitis	4.57e-05	0.00123	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ADSL—atopic dermatitis	4.54e-05	0.00123	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL10—atopic dermatitis	4.43e-05	0.0012	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT6—atopic dermatitis	4.43e-05	0.0012	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL5—atopic dermatitis	4.39e-05	0.00119	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCL5—atopic dermatitis	4.35e-05	0.00118	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL17—atopic dermatitis	4.33e-05	0.00117	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—TAC1—atopic dermatitis	4.29e-05	0.00116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—NPS—atopic dermatitis	4.29e-05	0.00116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCR3—atopic dermatitis	4.21e-05	0.00114	CbGpPWpGaD
Oxycodone—OPRD1—GPCR ligand binding—CXCL8—atopic dermatitis	4.19e-05	0.00113	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CMA1—atopic dermatitis	4.13e-05	0.00112	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL11—atopic dermatitis	4.13e-05	0.00112	CbGpPWpGaD
Oxycodone—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	4.08e-05	0.0011	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL10—atopic dermatitis	4.03e-05	0.00109	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL5—atopic dermatitis	3.99e-05	0.00108	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCL5—atopic dermatitis	3.95e-05	0.00107	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CCR5—atopic dermatitis	3.92e-05	0.00106	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT6—atopic dermatitis	3.88e-05	0.00105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KIF3A—atopic dermatitis	3.86e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR3—atopic dermatitis	3.84e-05	0.00104	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCL5—atopic dermatitis	3.82e-05	0.00103	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL10—atopic dermatitis	3.75e-05	0.00101	CbGpPWpGaD
Oxycodone—OPRK1—GPCR ligand binding—CXCL8—atopic dermatitis	3.68e-05	0.000994	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CCR5—atopic dermatitis	3.56e-05	0.000963	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CMA1—atopic dermatitis	3.49e-05	0.000943	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL11—atopic dermatitis	3.49e-05	0.000943	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCL5—atopic dermatitis	3.47e-05	0.000937	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CCR5—atopic dermatitis	3.44e-05	0.000929	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GLB1—atopic dermatitis	3.42e-05	0.000926	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NPS—atopic dermatitis	3.42e-05	0.000925	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TAC1—atopic dermatitis	3.42e-05	0.000925	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL10—atopic dermatitis	3.4e-05	0.00092	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR3—atopic dermatitis	3.37e-05	0.00091	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCR3—atopic dermatitis	3.36e-05	0.000907	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ADSL—atopic dermatitis	3.28e-05	0.000887	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT6—atopic dermatitis	3.28e-05	0.000887	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCL5—atopic dermatitis	3.23e-05	0.000872	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL5—atopic dermatitis	3.18e-05	0.00086	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CCR5—atopic dermatitis	3.12e-05	0.000844	CbGpPWpGaD
Oxycodone—OPRM1—GPCR ligand binding—CXCL8—atopic dermatitis	3.11e-05	0.00084	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NPS—atopic dermatitis	3e-05	0.000811	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TAC1—atopic dermatitis	3e-05	0.000811	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCR3—atopic dermatitis	2.94e-05	0.000795	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCL5—atopic dermatitis	2.93e-05	0.000792	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CCR5—atopic dermatitis	2.91e-05	0.000786	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR3—atopic dermatitis	2.85e-05	0.000769	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL5—atopic dermatitis	2.79e-05	0.000754	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL10—atopic dermatitis	2.71e-05	0.000733	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CCR5—atopic dermatitis	2.64e-05	0.000713	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TAC1—atopic dermatitis	2.54e-05	0.000686	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NPS—atopic dermatitis	2.54e-05	0.000686	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCR3—atopic dermatitis	2.49e-05	0.000672	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GLB1—atopic dermatitis	2.43e-05	0.000658	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL10—atopic dermatitis	2.38e-05	0.000643	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.37e-05	0.000641	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL5—atopic dermatitis	2.36e-05	0.000637	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCL5—atopic dermatitis	2.33e-05	0.000631	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADSL—atopic dermatitis	2.33e-05	0.000631	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—IL2—atopic dermatitis	2.27e-05	0.000612	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NGF—atopic dermatitis	2.16e-05	0.000585	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—CXCL8—atopic dermatitis	2.15e-05	0.000582	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCR5—atopic dermatitis	2.1e-05	0.000569	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—CXCL8—atopic dermatitis	2.08e-05	0.000562	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL2—atopic dermatitis	2.06e-05	0.000556	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCL5—atopic dermatitis	2.05e-05	0.000553	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL10—atopic dermatitis	2.01e-05	0.000543	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—IL2—atopic dermatitis	1.99e-05	0.000537	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NGF—atopic dermatitis	1.9e-05	0.000513	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—CXCL8—atopic dermatitis	1.89e-05	0.00051	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCR5—atopic dermatitis	1.84e-05	0.000499	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL2—atopic dermatitis	1.8e-05	0.000488	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NFKBIA—atopic dermatitis	1.78e-05	0.000482	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—CXCL8—atopic dermatitis	1.76e-05	0.000475	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCL5—atopic dermatitis	1.73e-05	0.000468	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—IL2—atopic dermatitis	1.68e-05	0.000454	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NGF—atopic dermatitis	1.6e-05	0.000433	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—atopic dermatitis	1.6e-05	0.000431	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GLB1—atopic dermatitis	1.59e-05	0.00043	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NFKBIA—atopic dermatitis	1.56e-05	0.000423	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCR5—atopic dermatitis	1.56e-05	0.000421	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PPARA—atopic dermatitis	1.54e-05	0.000416	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADSL—atopic dermatitis	1.53e-05	0.000413	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—atopic dermatitis	1.52e-05	0.000412	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NFKBIA—atopic dermatitis	1.32e-05	0.000357	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—atopic dermatitis	1.27e-05	0.000344	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—atopic dermatitis	1.22e-05	0.000329	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—atopic dermatitis	1.21e-05	0.000327	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK8—atopic dermatitis	1.12e-05	0.000302	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—atopic dermatitis	1.12e-05	0.000301	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PPARA—atopic dermatitis	1.11e-05	0.0003	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—atopic dermatitis	1.07e-05	0.000288	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—atopic dermatitis	1.06e-05	0.000287	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK8—atopic dermatitis	9.81e-06	0.000265	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—atopic dermatitis	9.42e-06	0.000255	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—atopic dermatitis	9.01e-06	0.000243	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—atopic dermatitis	8.96e-06	0.000242	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK8—atopic dermatitis	8.29e-06	0.000224	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPARA—atopic dermatitis	7.9e-06	0.000214	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—atopic dermatitis	7.14e-06	0.000193	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—atopic dermatitis	6.26e-06	0.000169	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—atopic dermatitis	5.29e-06	0.000143	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPARA—atopic dermatitis	5.17e-06	0.00014	CbGpPWpGaD
